GALVmed chief scientific officer: 'I don't think people foresaw the worldwide scale of ASF'

摘要

In light of the spread of African swine fever (ASF) in Europe and Asia, Animal Pharm editor Joseph Harvey spoke to someone who has lengthy experience in vaccine development from both a research and commercial perspective. Jeremy Salt - GALVmed's chiefscientific officer - gave his viewpoint on how close the industry might be to an ASF preventative.With ASF weighing heavy on China, it is no surprise domestic companies are scrambling for a preventative. Guangdong Highsun Group claimed it had an ASF vaccine ready for commercialization. No sooner had these comments been made, the Chinese government had refuted their veracity and a glimmer of hope had been extinguished.